CN110250509A - 一种改善关节健康的组合物及其制备方法 - Google Patents
一种改善关节健康的组合物及其制备方法 Download PDFInfo
- Publication number
- CN110250509A CN110250509A CN201910493840.9A CN201910493840A CN110250509A CN 110250509 A CN110250509 A CN 110250509A CN 201910493840 A CN201910493840 A CN 201910493840A CN 110250509 A CN110250509 A CN 110250509A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- articulation health
- improving
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000036541 health Effects 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims description 9
- 102000008186 Collagen Human genes 0.000 claims abstract description 17
- 108010035532 Collagen Proteins 0.000 claims abstract description 17
- 229920001436 collagen Polymers 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 10
- 239000002552 dosage form Substances 0.000 claims abstract description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 6
- 239000011718 vitamin C Substances 0.000 claims abstract description 6
- 241001072261 Musculista senhousia Species 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 5
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims abstract description 4
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims abstract description 4
- 229950006780 n-acetylglucosamine Drugs 0.000 claims abstract description 4
- 235000013305 food Nutrition 0.000 claims abstract description 3
- 239000011149 active material Substances 0.000 claims description 12
- 235000013361 beverage Nutrition 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 235000015110 jellies Nutrition 0.000 claims description 4
- 239000008274 jelly Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000013355 food flavoring agent Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- -1 oral solution Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000000375 suspending agent Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- 229940100688 oral solution Drugs 0.000 claims 1
- 238000005461 lubrication Methods 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 4
- 208000006820 Arthralgia Diseases 0.000 abstract description 3
- 210000001188 articular cartilage Anatomy 0.000 abstract description 3
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 10
- 201000008482 osteoarthritis Diseases 0.000 description 10
- 239000000047 product Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229960002442 glucosamine Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 208000003947 Knee Osteoarthritis Diseases 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229960002849 glucosamine sulfate Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种改善关节健康的组合物，由以下重量份原料制备：胶原蛋白肽100‑1000份，含Ⅱ型胶原蛋白软骨粉0.5‑5份，N‑乙酰葡萄糖胺5‑50份，绿贻贝粉50‑500份，维生素C 5‑50份。上述原料加入辅料混合制成常规食品保健品剂型。本发明的组合物既能缓解关节疼痛症状，促进关节润滑，更能促进关节软骨的修复再生，从根本上改善关节健康。本发明可以丰富市场上的关节保健产品，让消费者有更多的选择。
Description
技术领域
本发明涉及一种保健食品及其制备方法，特别涉及一种改善关节健康的组合物及其制备方法。
背景技术
骨关节炎为困扰中老年人群的一种常见退行性病变，据国内外调查发现60岁以上人群骨关节炎的患病概率达50％，75岁以上人群则高达80％。骨关节炎以关节软骨的丢失、软骨的增厚、骨赘的形成为其病理特征，疼痛与功能障碍为其主要临床症状。疾病终末期常需行关节置换术，但该术式为骨关节炎终末期的治疗手段。世界卫生组织已将2000～2010年定为“骨关节十年”，将2010～2020年定义为第二个“骨关节十年”，可见骨关节健康受到世界卫生组织的高度重视。
目前，药物治疗作为骨关节炎的一线疗法。目前用于骨关节炎的药物主要为非甾体类抗炎药，具有消炎和止痛作用，但只能治标不能治本。而且各种药物多存在易用性、安全性、不良反应、副作用等缺陷。
针对骨关节炎保健食品产品主要是氨基葡萄糖和硫酸软骨素，该类产品对缓解关节疼痛和关节润滑一定程度的改善作用，但消炎作用弱，还是不能从根本上解决关节问题。而且这类产品趋于雷同，功能上也是参差不齐。
发明内容
为了解决现有技术中的问题，本发明提供一种改善关节健康的组合物及其制备方法，解决现有市场上的关节保健产品趋于雷同，功效不显著，同质化严重的问题。
本发明的技术方案是：
一种改善关节健康的组合物，由以下重量份原料制备：胶原蛋白肽100-1000份，含Ⅱ型胶原蛋白软骨粉0.5-5份，N-乙酰葡萄糖胺5-50份。
所述原料还包括绿贻贝粉50-500份，维生素C 5-50份。
一种改善关节健康的组合物的制备方法，包括以下步骤：
(1)按照配方将原料混合，得到活性物料；
(2)将活性物料与辅料混合制成常规食品保健品剂型。
所述辅料包括调味剂、稀释剂、助悬剂、助流剂、抗结剂、崩解剂、粘合剂。
所述剂型包括固体饮料、饮料、压片糖果、凝胶糖果、果冻、软糖、粉剂、颗粒剂、口服液、硬胶囊、软胶囊。
本发明的有益效果为：
本发明从关节健康的三个维度出发：通过补充胶原蛋白肽，可以促进软骨的修复和再生；含Ⅱ型胶原蛋白软骨粉良好的抗炎止痛作用，缓解关节疼痛；N-乙酰葡萄糖胺，可以促进关节液中透明质酸的合成，帮助关节润滑。绿贻贝粉天然含有氨基葡萄糖成分和糖胺聚糖，对软骨细胞的更新和关节润滑都有良好的作用。维生素C可以促进骨胶原蛋白在体内的吸收合成，同时具有良好的抗氧化作用。本发明的组合物既能缓解关节疼痛症状，促进关节润滑，更能促进关节软骨的修复再生，从根本上改善关节健康。本发明可以丰富市场上的关节保健产品，让消费者有更多的选择。
本发明为改善关节健康的功能食品，通过多种原料的合理配伍组方，协同增效，具有补充关节营养，促进关节修复，促进关节润滑、抗炎止痛，对关节炎或关节运动受损者有良好的治疗和预防作用。
具体实施方式
下面对本发明作进一步的详细说明。
实施例1
按照以下配方称取原料：胶原蛋白肽1000份，含Ⅱ型胶原蛋白软骨粉0.5份，N-乙酰葡萄糖胺50份,混合，得到活性物料；将活性物料加入柠檬果粉、三氯蔗糖、阿拉伯胶，制成固体饮料剂型。
实施例2
按照以下配方称取原料：胶原蛋白肽100份，含Ⅱ型胶原蛋白软骨粉5份，N-乙酰葡萄糖胺5份,混合，得到活性物料；将活性物料加入水、蓝莓浓缩汁、柠檬酸、甜菊糖苷，制成液体饮料剂型。
实施例3
按照以下配方称取原料：胶原蛋白肽1000份，含Ⅱ型胶原蛋白软骨粉0.5份，N-乙酰葡萄糖胺50份,绿贻贝粉50份，维生素C 50份，混合，得到活性物料；将活性物料加入异麦芽酮糖醇、山梨糖醇、糊精、硬脂酸镁，制成压片糖果剂型。
实施例4
按照以下配方称取原料：胶原蛋白肽100份，含Ⅱ型胶原蛋白软骨粉5份，N-乙酰葡萄糖胺5份,绿贻贝粉500份，维生素C 5份，混合，得到活性物料；将活性物料加入水、果冻粉、赤藓糖醇、罗汉果苷、柠檬酸，制成凝胶果冻剂型。
试验例
一、功效试服实验：
1、实验方案：采用国际公认的VAS评分、WOMAC骨关节炎指数作为临床观察指标，进行评分，每2周1次，治疗4周，对所测数据进行统计学分析，观察各组患者治疗前后各项指标的变化及治疗前后疗效及组间疗效差别。
2、实验人员：选取膝骨关节炎患者60人。
3、实验周期：4周。
4、实验样品：实验组：按照上述优化配方：实施例1，制成改善关节健康的固体饮料饮品，每日1袋，冲服。对照组：市售氨糖硫酸软骨素产品：2g/次，每日2次。
5、实验结果：
治疗结果实验组、对照组治疗前后VAS、WOMAC指数评分，结果详见表1，表2。实验组第4周与第0周结果有显著差异(P＜0.05)；对照组第4周与第0周结果有显著差异(P＜0.05)。实验组和对照组第4周结果无显著性(P＞0.05)。结果表明：实验组与对照组都有明显的治疗效果。
表1两组治疗前后VAS评分对比情况(x±s，分值，n＝30)
表2两组治疗前后WOMAC指数对比情况(x±s，分值，n＝30)
疗效判定标准参考《中药新药治疗骨性关节炎的临床研究指导原则》。结果详见表3。结果表明：实验组的总体效果优于对照组，总有效率为86.7％。
表3两组临床疗效比较(例，n＝30)
以上所述仅为本发明的优选实施方式，凡是利用本发明说明书内容所作的若干改进或变形，或直接或间接运用在其他相关的技术领域，也应视为在本发明的专利保护范围内。
Claims (5)
1.一种改善关节健康的组合物，其特征在于，由以下重量份原料制备：胶原蛋白肽100-1000份，含Ⅱ型胶原蛋白软骨粉0.5-5份，N-乙酰葡萄糖胺5-50份。
2.根据权利要求1所述改善关节健康的组合物，其特征在于，所述原料还包括绿贻贝粉50-500份，维生素C5-50份。
3.一种权利要求1或2改善关节健康的组合物的制备方法，其特征在于，包括以下步骤：
(1)按照配方将原料混合，得到活性物料；
(2)将活性物料与辅料混合制成常规保健食品剂型。
4.根据权利要求3所述改善关节健康的组合物的制备方法，其特征在于，所述辅料包括调味剂、稀释剂、助悬剂、助流剂、抗结剂、崩解剂、粘合剂。
5.根据权利要求3所述改善关节健康的组合物的制备方法，其特征在于，所述剂型包括固体饮料、饮料、压片糖果、凝胶糖果、果冻、软糖、粉剂、颗粒剂、口服液、硬胶囊、软胶囊。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910493840.9A CN110250509A (zh) | 2019-06-07 | 2019-06-07 | 一种改善关节健康的组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910493840.9A CN110250509A (zh) | 2019-06-07 | 2019-06-07 | 一种改善关节健康的组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110250509A true CN110250509A (zh) | 2019-09-20 |
Family
ID=67917216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910493840.9A Withdrawn CN110250509A (zh) | 2019-06-07 | 2019-06-07 | 一种改善关节健康的组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110250509A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202005017053U1 (de) * | 2005-10-28 | 2006-01-05 | Weber & Weber Gmbh & Co. Kg | Nährstoffpräparat, insbesondere geeignet für die nutritive Ergänzung bei erhöhter Gelenkbeanspruchung und Gelenkerkrankungen |
| CN103238839A (zh) * | 2013-05-15 | 2013-08-14 | 百岳特生物科技（上海）有限公司 | 用于保养关节的含胶原蛋白的食品组成物 |
| CN108065367A (zh) * | 2017-12-13 | 2018-05-25 | 上海锐因生物科技有限公司 | 一种用于关节保健的组合物及其制备方法 |
| CN109567157A (zh) * | 2018-10-23 | 2019-04-05 | 北京同仁堂健康药业股份有限公司 | 一种用于改善骨关节健康的组合物及其制备方法 |
-
2019
- 2019-06-07 CN CN201910493840.9A patent/CN110250509A/zh not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202005017053U1 (de) * | 2005-10-28 | 2006-01-05 | Weber & Weber Gmbh & Co. Kg | Nährstoffpräparat, insbesondere geeignet für die nutritive Ergänzung bei erhöhter Gelenkbeanspruchung und Gelenkerkrankungen |
| CN103238839A (zh) * | 2013-05-15 | 2013-08-14 | 百岳特生物科技（上海）有限公司 | 用于保养关节的含胶原蛋白的食品组成物 |
| CN108065367A (zh) * | 2017-12-13 | 2018-05-25 | 上海锐因生物科技有限公司 | 一种用于关节保健的组合物及其制备方法 |
| CN109567157A (zh) * | 2018-10-23 | 2019-04-05 | 北京同仁堂健康药业股份有限公司 | 一种用于改善骨关节健康的组合物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 王海燕等: "非变性Ⅱ型胶原蛋白改善骨关节炎的研究进展", 《食品工业科技》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102949710B (zh) | 增加骨密度的药物组合物或保健品及其制备方法 | |
| CN102150836A (zh) | 氨糖多肽软胶囊 | |
| CN101711786B (zh) | 一种用于缓解骨关节病、增强免疫力的制剂 | |
| CN102988406A (zh) | 用于抑制发炎的医药组合物及套组 | |
| CN111467481A (zh) | 一种改善和/或预防骨关节炎的组合物及其应用 | |
| CN104645332A (zh) | 用于缓解和预防关节炎的药物组合物 | |
| CN104382005A (zh) | 一种氨糖软骨素胶原蛋白片及其制备方法 | |
| CN102210699A (zh) | 壳寡糖在制备防治心脑血管疾病药物中的应用 | |
| CN101455396A (zh) | 一种促进骨和骨关节健康的营养保健食品 | |
| CN105124583A (zh) | 一种增强骨密度的保健食品及其制备方法 | |
| CN107156849A (zh) | 一种含姜黄素的关节保健组合物及其应用 | |
| CN102441023B (zh) | 一种治疗骨科疾病的注射用组合物 | |
| CN102711783A (zh) | 含有黄芪提取物的、加速新陈代谢的组合物 | |
| JP2007099653A (ja) | 関節痛改善剤 | |
| CN110250509A (zh) | 一种改善关节健康的组合物及其制备方法 | |
| CN110269251A (zh) | 一种通便促排的组合物及其制备方法 | |
| CN105982911A (zh) | 一种氨基葡萄糖和玻璃酸钠组合的高粘弹性注射液的制备方法 | |
| CN109464651A (zh) | 一种软骨代谢异常疾病改善用健康食品及药品组合物 | |
| CN102138961A (zh) | 黑豆皮提取物在预防和治疗骨关节炎的产品中的应用 | |
| CN103238839A (zh) | 用于保养关节的含胶原蛋白的食品组成物 | |
| RU2145228C1 (ru) | Профилактическое и общеукрепляющее средство широкого спектра действия | |
| CN105998370A (zh) | 一种用于治疗和预防骨质疏松的组合物 | |
| RU2327478C1 (ru) | Композиция, стимулирующая регенерацию опорных тканей (варианты) | |
| CN1250239C (zh) | 一种治疗腰痛病的药物及制备方法 | |
| CN111135284A (zh) | 提高骨密度的组合物及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190920 |
|
| WW01 | Invention patent application withdrawn after publication |